Poordad FF - Search Results

Year	Number of Results
1997	1
1999	1
2001	2
2002	5
2003	3
2004	9
2005	4
2006	1
2007	1
2009	2
2010	4
2011	2
2013	3
2014	2
2015	1
2023	1
2024	0

1

Presentation and complications associated with cirrhosis of the liver.

Poordad FF. Poordad FF. Curr Med Res Opin. 2015 May;31(5):925-37. doi: 10.1185/03007995.2015.1021905. Curr Med Res Opin. 2015. PMID: 25697811 Review.

2

Imatinib (Gleevec)-induced hepatotoxicity.

Ayoub WS, Geller SA, Tran T, Martin P, Vierling JM, Poordad FF. Ayoub WS, et al. Among authors: poordad ff. J Clin Gastroenterol. 2005 Jan;39(1):75-7. J Clin Gastroenterol. 2005. PMID: 15599217

3

Review article: the burden of hepatic encephalopathy.

Poordad FF. Poordad FF. Aliment Pharmacol Ther. 2007 Feb;25 Suppl 1:3-9. doi: 10.1111/j.1746-6342.2006.03215.x. Aliment Pharmacol Ther. 2007. PMID: 17295846 Free article. Review.

4

Sirolimus-induced hyperlipidaemia in liver transplant recipients is not dose-dependent.

Firpi RJ, Tran TT, Flores P, Nissen N, Colquhoun S, Shackleton C, Martin P, Vierling JM, Poordad FF. Firpi RJ, et al. Among authors: poordad ff. Aliment Pharmacol Ther. 2004 May 1;19(9):1033-9. doi: 10.1111/j.1365-2036.2004.01923.x. Aliment Pharmacol Ther. 2004. PMID: 15113371 Free article. Review.

5

Pivoting to telemedicine in a single-day multidisciplinary liver tumor clinic during COVID-19: the Texas Liver Tumor Center experience.

Crow KS, Poordad FF, Halff GA, Cigarroa FG, Tsai E, Infante IV, Arora SP. Crow KS, et al. Among authors: poordad ff. Ann Palliat Med. 2023 Nov;12(6):1310-1317. doi: 10.21037/apm-23-357. Epub 2023 Oct 23. Ann Palliat Med. 2023. PMID: 37953220 Free article. Review.

6

Developments in hepatitis C therapy during 2000-2002.

Poordad FF, Tran T, Martin P. Poordad FF, et al. Expert Opin Emerg Drugs. 2003 May;8(1):9-25. doi: 10.1517/14728214.8.1.9. Expert Opin Emerg Drugs. 2003. PMID: 14610908 Review.

7

Pathophysiologic basis for the medical management of portal hypertension.

Poordad FF, Sigal SH, Brown RS. Poordad FF, et al. Expert Opin Pharmacother. 2009 Feb;10(3):453-67. doi: 10.1517/14656560802707853. Expert Opin Pharmacother. 2009. PMID: 19191681 Review.

8

IDN-6556 Idun Pharmaceuticals Inc.

Poordad FF. Poordad FF. Curr Opin Investig Drugs. 2004 Nov;5(11):1198-204. Curr Opin Investig Drugs. 2004. PMID: 15573871 Review.

9

Virological relapse in chronic hepatitis C.

Poordad FF, Flamm SL. Poordad FF, et al. Antivir Ther. 2009;14(3):303-13. Antivir Ther. 2009. PMID: 19474464 Review.

10

Liver transplant and recurrent disease.

Poordad FF. Poordad FF. Clin Liver Dis. 2004 May;8(2):461-73. doi: 10.1016/j.cld.2004.02.011. Clin Liver Dis. 2004. PMID: 15481350 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

40 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year